Martin Lee David, Fikree Asma, Zarate-Lopez Natalia, Martinkova Karin, Brugaletta Concetta, Perrin Chris, Philpot Ursula
University College London Hospital NHS Foundation Trust, Nutrition and Dietetics, London, UK.
GI Physiology Unit, University College London Hospital NHS Foundation Trust, London, UK.
Neurogastroenterol Motil. 2025 Apr 6:e70043. doi: 10.1111/nmo.70043.
Avoidant/restrictive food intake disorder (ARFID) is common among adults with disorders of gut-brain interaction (DGBI) presenting to gastroenterology settings. Symptoms overlap between ARFID and DGBI. How the severity of ARFID is defined can impact rates of diagnosis. Importantly, a diagnosis of ARFID can only be applied when the eating disturbance exceeds that expected from the DGBI condition. This leads to diagnostic challenges for the gastroenterology team. We aimed to explore how we could better identify "ARFID presentation" by reaching a clinically meaningful cut-off and distinct categories for separating DGBI from ARFID and where DGBI and ARFID overlap.
A retrospective review of electronic health records (EHR) was conducted on 33 patients 88% female (29/33), with a median age of 44.3 ± 15.5 (range 18-73 years). All had a Rome IV diagnosed DGBI and were refractory to standard medical care, requiring both gastro-psychology and dietitian input in a tertiary care Neurogastroenterology service during 2019. Severity criteria for meeting either strict or lenient ARFID criteria A were defined based on DSM-5 and best practice recommendations.
The majority (82%) met a form of ARFID criteria A. However, by applying severity levels, 33% met criteria for strict ARFID, while 49% met lenient criteria, and 18% did not meet any criteria.
Adults with refractory DGBI who require both dietetic and psychological support can meet both lenient and strict ARFID severity criteria. Future research should explore if utilizing severity markers can help separate the heterogeneity of DGBI + ARFID and inform diagnostic and treatment approaches.
回避/限制性食物摄入障碍(ARFID)在就诊于胃肠病科的肠-脑互动障碍(DGBI)成人患者中很常见。ARFID与DGBI的症状存在重叠。ARFID严重程度的定义方式会影响诊断率。重要的是,只有当进食障碍超过DGBI疾病预期的程度时,才能做出ARFID的诊断。这给胃肠病学团队带来了诊断挑战。我们旨在探索如何通过确定一个具有临床意义的临界值以及区分DGBI与ARFID以及二者重叠情况的不同类别,来更好地识别“ARFID表现”。
对33例患者的电子健康记录(EHR)进行回顾性分析,其中88%为女性(29/33),中位年龄为44.3±15.5岁(范围18 - 73岁)。所有患者均经罗马IV标准诊断为DGBI,且对标准医疗护理无效,2019年期间在三级神经胃肠病学服务中心需要胃肠心理学和营养师的参与。根据《精神疾病诊断与统计手册》第5版(DSM - 5)和最佳实践建议,定义了符合严格或宽松ARFID标准A的严重程度标准。
大多数(82%)符合某种形式的ARFID标准A。然而,通过应用严重程度分级,33%符合严格ARFID标准,49%符合宽松标准,18%不符合任何标准。
需要饮食和心理支持的难治性DGBI成人患者可能符合宽松和严格的ARFID严重程度标准。未来的研究应探索利用严重程度标志物是否有助于区分DGBI + ARFID的异质性,并为诊断和治疗方法提供依据。